Andrew Reardon

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

LGND

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Ligand Pharmaceuticals Inc (LGND)	Chief Legal Officer and Secretary	$476,675	—	$1,656,171	$1,332,345	$268,800	$13,291	$3,747,282
2024	Ligand Pharmaceuticals Inc (LGND)	Chief Legal Officer and Secretary	$451,950	—	$1,428,806	$1,142,820	$240,000	$7,380	$3,270,956
2023	Ligand Pharmaceuticals Inc (LGND)	Chief Legal Officer and Secretary	$434,262	—	$1,126,169	$596,045	$173,705	$6,900	$2,337,081
2022	Ligand Pharmaceuticals Inc (LGND)	Chief Legal Officer and Secretary	$172,917	—	$1,023,470	$1,746,108	$62,250	$2,909	$3,007,654

No earnings-call appearances or filed executive changes recorded yet.